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Background-—Experimental studies have demonstrated that lead and cadmium have direct toxic effects on the myocardium, but
the few human studies are limited by design, assessment of exposure, and use of heart failure as a late-stage endpoint.
Methods and Results-—In a prospective population study, we studied the association of left ventricular (LV) function with blood
lead (BPb) and 24-hour urinary cadmium (UCd). In 179 participants randomly recruited from a Flemish population (50.3% women;
mean age 39.1 years), geometric mean BPb and UCd at enrollment (1985-2000) were 0.20 lmol/L and 6.1 nmol, respectively.
We assessed systolic and diastolic LV function 11.9 years (median) later (2005-2010) by using Doppler imaging of the transmitral
blood ﬂow and the mitral annular movement and speckle tracking. In multivariable-adjusted linear regression, LV systolic function
decreased with BPb. For a doubling of exposure, estimates were 0.392% for global longitudinal strain (P=0.034), 0.618% and
0.113 s1 for regional longitudinal strain (P=0.028) and strain rate (P=0.008), and 0.056 s1 for regional radial strain rate
(P=0.050). Regional longitudinal strain rate (0.066 s1, P=0.009) and regional radial strain (2.848%, P=0.015) also decreased
with UCd. Models including both exposure indexes did not allow differentiating whether LV dysfunction was predominately related
to BPb or UCd. Diastolic LV function was not associated with BPb or UCd (P≥0.159).
Conclusions-—Although effect sizes were small, our results suggest that environmental exposure to lead, cadmium, or both might
be a risk factor for systolic LV dysfunction, a condition often proceeding to heart failure. ( J Am Heart Assoc. 2017;6:e004692.
DOI: 10.1161/JAHA.116.004692.)
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H eart failure is a major public health problem with aprevalence of nearly 6 million in the United States and
more than 23 million worldwide.1 Heart failure starts with risk
factors for left ventricular dysfunction, progresses to asymp-
tomatic changes in cardiac structure and function, and then
evolves into clinically overt disease. Diastolic heart failure,
also referred to as heart failure with normal ejection fraction,
accounts for 40% to 50% of all cases.2 Due to the
demographic transition, the incidence of heart failure rises
exponentially with age.1 Identiﬁcation of environmental trig-
gers of left ventricular dysfunction is therefore of major
importance.
In addition to potential secondary effects mediated via
hypertension3-5 or renal dysfunction,6,7 experimental studies
have demonstrated that lead and cadmium8-10 have direct
toxic effects on the myocardium. The currently available
human evidence linking cardiac dysfunction to exposure to
these metals originates from case-control reports11,12 or
cross-sectional studies,13 all involving lead-exposed work-
ers.11-13 A report from the second National Health and
Nutrition Examination Survey (NHANES) showed an associa-
tion between ECG left ventricular hypertrophy and the blood
lead concentration.14 Population studies linking left ventric-
ular function to environmental cadmium exposure focused on
heart failure in its terminal stage15-17 or on a composite
endpoint, including heart failure.18,19 Furthermore, in these
population studies the internal cadmium burden was esti-
mated from spot urines16,18 or blood cadmium.15,16 No study
differentiated between systolic and diastolic left ventricular
dysfunction using modern echocardiographic techniques.20 To
bridge these knowledge gaps, we related in a prospective
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population study systolic and diastolic echocardiographic left
ventricular function (2005-2010) to baseline measurements
of blood lead and 24-hour urinary cadmium (1985-2000).
Methods
Study Population
The Cadmium in Belgium (CadmiBel) study (1985-1989)21
included 1107 Flemish participants randomly recruited from 10
districts in northeastern Belgium.7 The participation rate was
78%.7 The geometric mean cadmium concentration in the soil
sampled from 85 kitchen gardens was 5.3 mg/kg (5th-95th
percentile interval, 1.4-18.9) in 6 districts, which bordered on 3
zinc/cadmium smelters, and 0.9 mg/kg (0.4-1.6) in 4 districts
that were more than 10 km away from the smelters.22 The
participants of the 10 districts had similar characteristics apart
from exposure to cadmium.7,23 From 1991 to 1995, partici-
pants were invited for follow-up in the Public Health and
Environmental Exposure to Cadmium Study (PheeCad).3 From
1996 until 2004, 1930 family members of the former partic-
ipants (1985-1990) were enrolled.24 At the time of recruitment,
inhabitants of the catchment area were white Flemish. The
2005-2010 cycle of ﬁeldwork included an echocardiographic
examination. Of 3037 former participants, 1208 were reinvited
by letter, of whom26 had died, 27were severely ill, and 100 had
moved out of the area. Of the remaining 1055 subjects, 828
renewed consent (participation rate 78.5%).
Study participants eligible for the current analysis had to
have their blood lead and 24-hour urinary cadmium measured
during at least 1 study period and to have undergone an
echocardiographic assessment of systolic and diastolic left
ventricular function. Of 210 participants complying with these
eligibility criteria, we excluded 31 from analysis because of
insufﬁcient quality of the echocardiographic images (n=22) or
because of previous myocardial infarction (n=3) or severe
valvular disease (n=6). Of the remaining 179 participants, 70
had a repeat exposure measurement prior to the echocardio-
graphic examination. Compared with the 649 participants
who underwent echocardiography but were not included in
our analyses, those analyzed had similar distributions of sex
(51.0% vs 50.3% women; P=0.864), age (51.2 versus
51.1 years; P=0.910), and body mass index (26.6 vs
26.5 kg/m2; P=0.979). However, analyzed participants had
a lower systolic blood pressure (130.2 vs 126.8 mm Hg;
P=0.022) with a higher prevalence of smokers (18.6% vs
26.8%; P=0.016) and drinkers consuming alcohol in excess of
5 g per day (38.7% vs 44.7%; P=0.008). The other cardiovas-
cular risk factors, such as diastolic blood pressure, total and
high-density lipoprotein (HDL) cholesterol, serum creatinine,
and plasma glucose were equally distributed between the 2
groups (P≥0.054).
The study complied with the Helsinki Declaration for
Investigation of Human Subjects.25 The Ethics Committee of
the University of Leuven, Belgium, approved the study and
follow-up of the participants. Participants gave or renewed
written informed consent at each contact.
Measurements at Baseline
Study nurses administered a questionnaire inquiring into each
participant’s occupational exposure to heavy metals. Partic-
ipants collected 24-hour urine samples in wide-neck poly-
ethylene containers for measurement of volume, cadmium,
and creatinine. Within 2 weeks of the urine collection, a
venous blood sample was obtained. Lead and cadmium were
measured by electrothermal atomic absorption spectrometry
with a stabilized-temperature platform furnace and Zeeman
background correction.21 The external quality-control program
did not show any time trend in the accuracy of the lead3 or
cadmium4 measurements. The detection limits for blood lead
and the urinary cadmium concentration were 0.08 lmol/L6
and 0.89 nmol/L26 for the 1985-1995 interval and thereafter
0.024 lmol/L and 0.18 nmol/L, respectively. We set 1 level
below the 1985-1995 blood lead threshold as the detection
limit. We used the baseline measurements of the heavy
metals as primary exposure variable in all participants or the
average of the baseline (1985-2000) and the follow-up
measurement (1991-2004) in 70 participants with repeat
assessment of the exposure variables.
Echocardiography at Follow-Up
A detailed description of the protocol for echocardiography is
available in previous publications.27-29 All echocardiographic
images were obtained with a Vivid7 Pro device (GE Vingmed,
Horten, Norway) interfaced with a 2.5- to 3.5-MHz phased-
array probe according to current guidelines.20 For postpro-
cessing, at least 5 cardiac cycles with a simultaneously
acquired ECG signal were digitally stored.
Left Ventricular Structure
The internal left ventricular diameter and interventricular
septal and posterior wall thicknesses were measured at end-
diastole from the 2-dimensionally guided M-mode tracings or
from correctly oriented 2-dimensional images when optimal
orientation of M-mode ultrasound beam could not be
achieved. End-diastolic left ventricular dimensions were used
to calculate left ventricular mass by an anatomically validated
formula.20 Left ventricular hypertrophy was a left ventricular
mass indexed to body surface area with the threshold set at
95 g/m2 in women and 115 g/m2 in men.30 Relative wall
thickness was the average of the interventricular and
posterior wall thickness divided by the end-diastolic diameter.
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Systolic Left Ventricular Function
Left ventricular ejection fraction was computed from the end-
systolic and end-diastolic volumes measured from the apical
4-chamber view, using the Simpson method.20 To measure 2-
dimensional global longitudinal strain, we selected at least 2
cardiac cycles with optimal image quality, and we used the Q-
Analysis of EchoPac BT113 software (GE Vingmed, Horten,
Norway).29 We manually traced the endocardial border with
the point-and-click option at the end-systolic frame of the 2-
dimensional images from the apical 4-chamber view. The
software with default settings, including data smoothing,
automatically tracked the myocardial speckle motion, creating
basal, middle, and apical regions of interest. Whenever
required for optimal visualization, we made manual adjust-
ments afterward of the automated segmental tracking results.
We excluded images from analysis if wall tracking was
insufﬁcient in 2 or more segments. The software then
generates the peak systolic endocardial, midwall, and epicar-
dial global strain values. We carried global longitudinal strain
at the midwall further into our statistical analysis.29
To assess regional strain, we also recorded high-intensity
myocardial velocity signals using tissue Doppler imaging (TDI)
at a rate of at least 190 frames per second while adjusting the
imaging angle to ensure parallel alignment of the ultrasound
beam with the myocardial segment of interest. The Nyquist
limit was set as low as possible to avoid aliasing. We
positioned the TDI sample volume in the interrogated wall at
the level of the posterior tendinous chords and extracted the
strain and strain rate curves using the in-house-developed
SPEQLE software, version 4.6.2.27 The software allows
M-mode tracking of the myocardium to ensure that the
sample volume is maintained at the same position throughout
the cardiac cycle. We derived peak radial strain rate from the
spatial velocity gradient over a computational segment of
5 mm in the inferolateral wall and peak longitudinal strain rate
over 10-mm-long segments in the inferolateral and inferior
walls. With the ECG and blood ﬂow velocity through the aortic
valve providing time reference signals, the end-systolic strain
was the integral of mean strain rate over time. Henceforth we
refer to peak systolic strain rate and end-systolic strain as
strain rate and strain, which were averages of 3 cardiac cycles.
For longitudinal strain and strain rate, we averaged measure-
ments obtained at the inferolateral and inferior walls.27
Diastolic Left Ventricular Function
We measured peak early (E) and peak late (A) diastolic
velocity of the transmitral blood ﬂow and peak early (e0)
diastolic mitral annular velocities from tissue Doppler record-
ings at the septal, lateral, inferior, and posterior acquisition
sites, which were averaged for analysis.28 We computed the
E/e0 ratio as an index of left ventricular ﬁlling pressure.20 For
analysis, we averaged the indexes of diastolic function over 3
cardiac cycles.
Other Follow-Up Measurements
After participants had rested for 5 minutes in the sitting
position, nurses obtained 5 consecutive auscultatory blood
pressure readings (phase V diastolic pressure) using mercury
sphygmomanometers ﬁtted with an appropriately sized cuff.
The 5 readings were averaged for analysis. Hypertension was
a blood pressure of at least 140 mm Hg systolic or
90 mm Hg diastolic or use of antihypertensive drugs. Mean
arterial pressure was diastolic blood pressure plus one-third
of the difference between systolic and diastolic blood
pressure. Body mass index was weight in kilograms divided
by the square of height in meters. The waist-to-hip ratio was
waist circumference divided by hip circumference. The study
nurses administered a questionnaire providing information on
each participant’s recent medical history, smoking and
drinking habits, and intake of medications. Venous blood
samples, obtained after at least 6 hours fasting, were
analyzed for plasma glucose and serum creatinine, total and
HDL cholesterol, and c-glutamyltransferase as an index of
alcohol intake. Diabetes mellitus was a self-reported diagno-
sis, a fasting plasma glucose level of at least 126 mg/dL, or
use of antidiabetic agents.31
Statistical Analysis
For database management and statistical analysis, we used
SAS software version 9.4 (SAS Institute Inc, Cary, NC).
Departure from normality was evaluated by Shapiro-Wilk
statistic. Skewness and kurtosis were computed as the third
and fourth moments about the mean divided by the cube of
the standard deviation. The variables that required a logarith-
mic transformation to approximate the normal distribution
included blood lead, 24-hour urinary cadmium, and serum
c-glutamyltransferase. For logarithmically transformed vari-
ables, we reported central tendency and spread of data as
geometric mean and interquartile range, respectively. Signif-
icance was a 2-tailed a-level of 0.05 or less. Means and
proportions were compared using a large sample z-test and
Fisher exact test, respectively.
We assessed the association of left ventricular structure
and function with the biomarkers of exposure using multi-
variable linear regression. We adjusted the analyses for
covariables of possible physiological relevance27,29,32 mea-
sured at the time of echocardiography, including sex, age,
mean arterial pressure, heart rate, body mass index, fasting
plasma glucose, total-to-HDL cholesterol ratio, serum crea-
tinine, c-glutamyltransferase (as index of alcohol intake), and
smoking. In all models we also accounted for treatment with
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diuretics (thiazides, loop diuretics, and aldosterone antago-
nists), inhibitors of the renin-angiotensin system (b-blockers,
angiotensin-converting enzyme inhibitors, and angiotensin
type-1 receptor antagonists), and vasodilators (calcium-
channel blockers and a-blockers). In participants with base-
line and follow-up measurements of the heavy metals, we also
computed the size of the associations between left ventricular
function and exposure corrected for regression dilution bias,
using the quantile approach.33,34 Correcting for regression
dilution bias does not affect the signiﬁcance of the associ-
ations but provides more accurate estimates of their true
value.33,34
Results
Biomarkers of Exposure
At enrollment (1985-2000), geometric means of the exposure
biomarkers were 0.20 lmol/L (4.19 lg/dL) for blood lead
(interquartile range 0.12-0.38 lmol/L; 5th-95th percentile
interval 0.07-0.58 lmol/L) and 6.1 nmol (0.69 lg) for 24-
hour urinary cadmium (interquartile range 3.66-9.34 nmol;
5th-95th percentile interval 1.81-23.3 nmol). The logarithmi-
cally transformed distributions of the exposure biomarkers did
not deviate from normality (Figure 1). None of the participants
reported potential exposure to heavy metals at work or during
leisure time.
After a median interval of 5.3 years (interquartile range
4.9-5.7 years; 5th-95th percentile interval 4.6-6.1 years), 70
participants (39.1%) had their exposure biomarkers remea-
sured (1991-2004). From the ﬁrst to the second assessment,
blood lead dropped by 35.7% (95% conﬁdence interval 30.3%
to 41.0%; P<0.001) with a similar tendency for 24-hour
urinary cadmium (5.5%; 95% conﬁdence interval 3.5% to
14.6%; P=0.236).
Characteristics of Participants
All 179 participants were white Europeans, of whom 90
(50.3%) were women. Age averaged 39.1 years (interquartile
range 29.8-49.6 years; 5th-95th percentile interval 17.0-
62.5 years) at enrollment and at the time of the echocardio-
graphic examination 52.1 years (interquartile range 41.4-
60.6 years; 5th-95th percentile interval 23.0-74.1 years). The
median interval between enrollment and echocardiography
(2005-2010) was 11.9 years (interquartile range 6.3-
19.9 years; 5th-95th percentile interval 5.2-22.3 years).
Table 1 lists the characteristic of the participants at the time
of echocardiography by the medians of the distributions of the
exposure biomarkers. In regard to blood lead and 24-hour
urinary cadmium, people with high compared with low expo-
sure were 14.9 and 18.4 years older. More advanced age was
associated with a higher cardiovascular risk proﬁle as exem-
pliﬁed by higher mean values of body mass index, waist-to-hip
ratio, systolic and diastolic blood pressures, and prevalence of
hypertension and treated hypertension. In the whole study
population the number of patients on diuretics, inhibitors of the
renin-angiotensin system, and vasodilators amounted to 9
(5.0%), 31 (17.3%), and 8 (4.5%), respectively. Among these
patients, 30 (16.8%) were on monotherapy with a single drug
class, whereas 9 (5.0%) were on combination therapy.
Left Ventricular Structure
In line with the age distribution and the higher cardiovascular
risk proﬁle, people with higher exposure at enrollment (1985-
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Figure 1. Logarithmically transformed distributions of blood lead (A) and 24-hour urinary cadmium excretion (B) measured at baseline (1985-
2000). S and K are the coefﬁcients of skewness and kurtosis. The P-values are for departure of the actually observed distribution (full line) from
normality (dashed line) according to Shapiro-Wilk statistics.
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2000) had an increased left ventricular mass index and higher
relative wall thickness (Table 2). However, in multivariable-
adjusted analyses (Table 3), the associations of left ventric-
ular mass index, end-diastolic diameter, and relative wall
thickness with the biomarkers of exposure did not retain
signiﬁcance (P≥0.072). The only exception was a marginal
increase in the left ventricular end-diastolic internal diameter
by 0.086 cm (P=0.035) for a doubling of the 24-hour urinary
cadmium excretion.
Systolic Left Ventricular Function
In unadjusted analyses dichotomized by the median of blood
lead (Table 2), left ventricular global longitudinal strain
(P=0.004), regional longitudinal strain (P<0.001) and strain
rate (P=0.002), and radial strain (P=0.006) and strain rate
(P=0.009) all decreased with higher lead exposure. In similar
analyses (Table 2), only regional longitudinal strain (P=0.048)
and regional radial strain (P<0.001) and strain rate (P<0.001)
decreased with higher 24-hour urinary cadmium. There were
no differences (P≥0.094) in left ventricular ejection fraction
associated with the biomarkers of exposure (Table 2). Mul-
tivariable-adjusted analyses with effect sizes expressed for a
doubling of the exposure biomarkers conﬁrmed these ﬁndings
(Table 4). As in the unadjusted analyses (Table 2), the
multivariable-adjusted relations of left ventricular ejection
fraction with the exposure biomarkers were far from signif-
icant (P≥0.689). Global longitudinal strain (0.392%,
P=0.034), regional longitudinal strain (0.618%, P=0.028),
and strain rate (0.056 s1, P=0.008), and regional radial
strain rate (0.113 s1, P=0.050) all decreased with blood
lead concentration at enrollment (1985-2000) with the
Table 1. Characteristics of Participants (2005-2010) by Median Blood Lead and 24-Hour Urinary Cadmium (1985-2000)
Characteristic Blood Lead (lmol/L) 24-Hour Urinary Cadmium (nmol)
Limits <0.180 ≥0.180 <6.08 ≥6.08
Number of participants (%)
All participants in category 90 89 90 89
Women 47 (52.2) 43 (48.3) 47 (52.2) 43 (48.3)
Smokers 22 (23.4) 27 (30.3) 28 (31.1) 20 (22.5)
Drinking ≥5 g alcohol per day 46 (51.1) 34 (38.2) 43 (47.8) 37 (41.6)
Hypertension 16 (17.8) 40 (44.9)§ 18 (20.0) 38 (42.7)†
Antihypertensive treatment 11 (12.2) 28 (31.5)† 13 (14.4) 26 (29.2)*
Diabetes mellitus 2 (2.2) 2 (2.2) 2 (2.2) 2 (2.2)
Mean (SD) of characteristic
Age, y 43.7 (14.3) 58.6 (9.7)§ 41.9 (12.2) 60.3 (9.6)§
Body mass index, kg/m2 25.7 (3.6) 27.4 (4.4)† 25.1 (4.0) 28.0 (3.7)§
Waist-to-hip ratio 0.86 (0.08) 0.89 (0.09)† 0.86 (0.08) 0.89 (0.09)†
Office blood pressure
Systolic pressure, mm Hg 123.2 (13.0) 130.5 (16.1)† 122.5 (13.3) 131.2 (15.5)§
Diastolic pressure, mm Hg 77.4 (8.3) 80.4 (9.3)* 77.4 (9.0) 80.4 (8.6)*
Mean arterial pressure, mm Hg 92.6 (8.9) 97.1 (10.2)† 92.4 (9.6) 97.3 (9.5)‡
Heart rate, beats per minute 60.1 (9.2) 62.0 (8.6) 61.0 (9.7) 61.1 (8.2)
Biochemical data
Total cholesterol, mmol/L 5.17 (1.11) 5.47 (0.92)* 5.17 (1.05) 5.46 (0.99)
HDL cholesterol, mmol/L 1.44 (0.35) 1.48 (0.40) 1.49 (0.35) 1.43 (0.40)
Total/HDL cholesterol ratio 3.73 (0.96) 3.91 (1.05) 3.62 (0.94) 4.02 (1.04)†
Plasma glucose, mmol/L 4.82 (0.68) 4.87 (0.50) 4.73 (0.64) 4.96 (0.53)*
Serum creatinine, lmol/L 82.0 (14.0) 85.2 (14.7) 81.9 (13.9) 85.3 (14.7)
c-glutamyltransferase, units/L 20 (14-28) 24 (18-32) 20 (14-28) 24 (18-35)*
Hypertension was a blood pressure of ≥140 mm Hg systolic or ≥90 mm Hg diastolic or use of antihypertensive drugs. Diabetes mellitus was a fasting plasma glucose level of ≥7.0 mmol/
L or use of antidiabetic agents. For c-glutamyltransferase, values are geometric mean (interquartile range). HDL indicates high-density lipoprotein cholesterol.
Signiﬁcance of the between-group differences: *P≤0.05; †P≤0.01; ‡P≤0.001; §P<0.0001.
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exception of regional radial strain (P=0.062). Regional longi-
tudinal strain rate (0.066 s1, P=0.009) and radial strain
(2.848%, P=0.015) decreased with 24-hour urinary cad-
mium, whereas the associations of global longitudinal strain,
regional longitudinal strain, and radial strain rate with 24-hour
urinary cadmium were not signiﬁcant (P≥0.071). Table 4
additionally provides estimates of the association sizes
corrected for regression dilution bias. In models adjusted as
before that included both indexes of exposure, the associa-
tions of regional longitudinal and radial strain and strain rate
weakened to a nonsigniﬁcant level (Figure 2). The correlation
coefﬁcient between blood lead and 24-hour urinary cadmium
was 0.49, but the variance inﬂation factors for collinearity
between the 2 exposure measures were 2.2 or less. Finally,
sensitivity analyses, in which we averaged the biomarkers of
exposure in 70 participants with duplicate measurements,
Table 2. Echocardiographic Measurements (2005-2010) by Medians of the Exposure Biomarkers (1985-2000)
Characteristic Blood Lead (lmol/L) 24-Hour Urinary Cadmium (nmol)
Limits <0.180 ≥0.180 <6.08 ≥6.08
Participants in category, number 90 89 90 89
Left ventricular structure
Mass index, g/m2 84.0 (16.9) 93.0 (19.50)† 81.5 (12.9) 95.5 (21.0)§
Hypertrophy, n (%) 5 (5.6) 18 (20.2)† 2 (2.2) 21 (23.6)§
End-diastolic diameter, cm 5.05 (0.46) 4.99 (0.43) 5.01 (0.42) 5.04 (0.47)
Relative wall thickness 0.35 (0.06) 0.38 (0.05)§ 0.34 (0.04) 0.39 (0.06)§
Systolic function
Ejection fraction, % 67.7 (6.9) 69.1 (7.7) 67.3 (6.9) 69.5 (7.8)
Global longitudinal strain, % 20.0 (2.4) 18.9 (2.6)† 19.5 (2.4) 19.5 (2.8)
Regional longitudinal strain, % 22.9 (3.2) 21.0 (3.9)‡ 22.5 (3.0) 21.4 (4.2)*
Regional longitudinal strain rate, s1 1.34 (0.28) 1.24 (0.24)† 1.32 (0.23) 1.25 (0.29)
Regional radial strain, % 60.3 (12.2) 55.0 (12.7)† 61.2 (12.3) 54.0 (12.0)‡
Regional radial strain rate, s1 3.37 (0.68) 3.09 (0.73)† 3.44 (0.75) 3.02 (0.62)‡
Diastolic function
E peak, cm/s 78.6 (15.9) 72.4 (14.8)† 80.2 (15.9) 70.8 (14.0)§
E/A ratio 1.50 (0.51) 1.04 (0.32)§ 1.51 (0.48) 1.03 (0.33)§
e0, cm/s 13.1 (3.5) 9.9 (2.7)§ 13.5 (3.2) 9.5 (2.5)§
E/e0 ratio 6.29 (1.72) 7.71 (2.26)§ 6.18 (1.57) 7.83 (2.29)§
Values are mean (SD) except for left ventricular hypertrophy, for which number of participants (%) are given. Due to image quality, global longitudinal strain and radial strain were available
in 173 and 166 participants; the number of participants with exposure measurements </≥ median was 90/83 and 86/80 for blood lead, respectively, and 87/86 and 86/80 for 24-hour
urinary cadmium, respectively.
Signiﬁcance of the between-group differences: *P≤0.05; †P≤0.01; ‡P≤0.001, §P<0.0001.
Table 3. Multivariable-Adjusted Associations of Left Ventricular Structure (2005-2010) With the Exposure Biomarkers (1985-
2000) in 179 Participants
Characteristic Biomarker Estimate (95% Conﬁdence Interval) P Value
Left ventricular mass index, g/m2 Blood lead 1.399 (4.504 to 1.707) 0.375
Urinary cadmium 2.934 (0.623 to 6.491) 0.105
End-diastolic diameter, cm Blood lead 0.064 (0.134 to 0.006) 0.072
Urinary cadmium 0.086 (0.006 to 0.167) 0.035
Relative wall thickness Blood lead 0.0065 (0.0031 to 0.0162) 0.185
Urinary cadmium 0.0032 (0.008 to 0.0143) 0.578
HDL indicates high-density lipoprotein. Associations were adjusted for sex, age, mean arterial pressure, heart rate, body mass index, fasting plasma glucose, total-to-HDL cholesterol ratio,
serum creatinine, c-glutamyltransferase, smoking, and antihypertensive treatment (by drug class) and express the effect size for a doubling of the exposure biomarker.
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from which we excluded participants on antihypertensive drug
treatment, or with additional adjustment for the time interval
between echocardiography and the assessment of the
exposure, were conﬁrmatory.
Diastolic Left Ventricular Function
In unadjusted analyses (Table 2), the echocardiographic
indexes capturing left ventricular diastolic function decreased
with higher exposure. However, in view of their strong age
dependency, these associations disappeared in multivariable
analyses adjusted as before (P≥0.159; Table 5).
Discussion
The key ﬁndings of our current study can be summarized as
follows: (1) higher blood lead concentrations at baseline
predicted impaired systolic left ventricular function a decade
later; (2) regional longitudinal strain rate and regional radial
strain at follow-up were lower if the baseline 24-hour urinary
cadmium excretion was higher; and (3) diastolic left ventric-
ular function was not associated with exposure to lead or
cadmium. Mean values for regional longitudinal strain and
strain rate were 22.0% and 1.28 s1, and 57.7% and 3.24 s1
for regional radial strain and strain rate (Table 2). A doubling
of the exposure biomarkers, as shown in Table 3, was
associated with decreases in the longitudinal and radial strain
and strain rate by ~3% to 4%. However, the distributions of
blood lead and 24-hour urinary cadmium from the low to high
end showed a 100-fold increase in exposure. From this
viewpoint, the observed changes in left ventricular systolic
function were clinically meaningful. Furthermore, a recent
systematic review35 highlighted that left ventricular ejection
fraction does not accurately capture systolic function in
people with a value within the normal range (>45%) and that
therefore its use biases results to a null outcome. This may
explain the absence of any association between left ventric-
ular ejection fraction and the biomarkers of exposure in our
current study.
Experimental studies8-10 provided the scientiﬁc back-
ground for searching for association between left ventricular
function and exposure to lead or cadmium in humans and
suggested possible mechanisms for direct cardiotoxic effects.
Kopp and co-workers studied female hooded rats fed 5 ppm
cadmium, 5 ppm lead, or both via drinking water for
15 months.8,9 Growth and food and water intake were
comparable with those of controls. Perfused hearts of
exposed animals showed depressed myocardial contractility
and reduced positive inotropic responsiveness to isopro-
terenol.8 The depressed myocardial contractility was not due
to altered b-receptor function but to depressed phosphory-
lation of the myocardial contractile proteins.8 In anesthetized
rats exposed to cadmium and lead for 20 months according
to a similar protocol, cadmium selectively slowed conduction
proximal to the His bundle, whereas lead alone or combined
with cadmium impaired conductivity distal to the His bundle.9
Table 4. Multivariable-Adjusted Associations of Systolic Left Ventricular Function (2005-2010) With the Exposure Biomarkers
(1985-2000)
Characteristic (Number of Participants) Biomarker
Estimate (95% Conﬁdence Interval)
P ValueUncorrected Corrected
Ejection fraction, % (n=179) Blood lead 0.150 (1.019 to 1.320) 0.190 (1.293 to 1.675) 0.800
Urinary cadmium 0.283 (1.628 to 1.116) 0.327 (1.942 to 1.288) 0.689
Global longitudinal strain, % (n=173) Blood lead 0.392 (0.753 to 0.030) 0.497 (0.957 to 0.038) 0.034
Urinary cadmium 0.136 (0.579 to 0.308) 0.157 (0.669 to 0.355) 0.547
Regional longitudinal strain, % (n=179) Blood lead 0.618 (1.167 to 0.068) 0.784 (1.482 to 0.087) 0.028
Urinary cadmium 0.609 (1.271 to 0.053) 0.702 (1.467 to 0.061) 0.071
Regional longitudinal strain rate, s1 (n=179) Blood lead 0.056 (0.097 to 0.015) 0.071 (0.124 to 0.019) 0.008
Urinary cadmium 0.066 (0.115 to 0.017) 0.076 (0.133 to 0.019) 0.009
Regional radial strain, % (n=166) Blood lead 1.825 (3.740 to 0.090) 2.316 (4.748 to 0.115) 0.062
Urinary cadmium 2.848 (5.134 to 0.561) 3.287 (5.927 to 0.648) 0.015
Regional radial strain rate, s1 (n=166) Blood lead 0.113 (0.226 to 0.0002) 0.143 (0.287 to 0.0002) 0.050
Urinary cadmium 0.117 (0.254 to 0.019) 0.135 (0.292 to 0.022) 0.092
HDL indicates high-density lipoprotein. Associations were adjusted for sex, age, mean arterial pressure, heart rate, body mass index, fasting plasma glucose, total-to-HDL cholesterol ratio,
serum creatinine, c-glutamyltransferase, smoking, and antihypertensive treatment (by drug class) and express the effect size for a doubling of the exposure biomarker. Uncorrected and
corrected indicate whether association sizes were corrected for regression dilution bias using the quantile method (see Statistical Methods).
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Phosphorus-31 nuclear magnetic resonance spectroscopy
revealed depressed high-energy phosphate and glycerol-3-
phosphorylcholine concentrations in hearts of cadmium-
exposed rats.9 In perfused rat hearts,10 contractility and the
glycerol-3-phosphorylcholine content of the myocardium
changed with the amount of calcium in the perfusate (0.9-
5 mmol/L). The combination of 5.0 mmol/L calcium with 0.3
or 30 lmol/L lead resulted in signiﬁcant disturbances in
phosphoglyceride, glycolytic, and high-energy phosphate
pathways.10 These animal experiments8-10 produced evidence
for direct pathophysiologic changes in the absence of overt
heavy-metal toxicity, the main mechanisms being slowing
conductivity in the heart and dysregulation of energy
metabolism. In addition, the cardiotoxic effects of lead might
be partially related to interference with calcium-dependent
processes.10 At the other end of the spectrum, autopsy
studies of children who died from lead poisoning revealed
myocarditis characterized with interstitial ﬁbrosis.36
To our knowledge, few studies in workers addressed the
possible association of left ventricular structure or function
with exposure to heavy metals. None of these worker studies
addressed cadmium exposure. In 105 laborers, left ventricular
mass index increased across thirds of the distributions of the
cumulative blood lead level and the time-weighted average
blood lead, but these associations lost signiﬁcance in adjusted
analyses of exposure analyzed as a continuous variable.13 In a
Polish study of 88 exposed workers and 55 controls,11 blood
lead levels averaged 30.4 lg/dL (1.47 lmol/L) and 12.2 lg/
dL (0.59 lmol/L), respectively. In the group exposed to lead
the end-diastolic left ventricular internal diameter was 6%
higher with a 3% decreased ejection fraction and an 11% raised
left ventricular mass index.11 In another case-control study the
transmitral E peak velocity and E/A ratio of 69 exposed
workers were signiﬁcantly lower than those in 38 controls,12
suggesting impaired left ventricular function.
Turning to population studies, the available data relating
heart failure to exposure to heavy metals are conﬁned to
cadmium. In a 15-year follow-up study on the population of
the heavily cadmium-polluted Kakehashi River basin in
Ishikawa Prefecture, Japan, the standardized mortality rate
of heart failure was higher in inhabitants with renal tubular
dysfunction, as evidenced by a urinary concentration of
retinol-binding protein or b2-microglobulin exceeding 4 lg/L
or 1 mg per gram creatinine, respectively.37,38 An analysis of
0.50-0.5-1.5 -1.0
Longitudinal strain (%)
–0.488 (–1.105 to 0.13) P=0.121
P=0.362–0.343 (–1.083 to 0.398)
A
2.00-2.0-6.0 -4.0
Radial strain  (%)
–0.957 (–3.084 to 1.170) P=0.375
P=0.074–2.332 (–4.891 to 0.227)
C
0.100-0.10-0.30 -0.20
Radial strain rate (s  )
–0.087 (–0.213 to 0.039) P=0.176
P=0.362–0.070 (–0.222 to 0.082)
D
-1
0.050-0.05-0.15 -0.10
Longitudinal strain rate (s  )
–0.039 (–0.085 to 0.0071) P=0.097
P=0.112–0.375 (–1.080 to 0.401)
B
-1
Lead
Cadmium
Figure 2. Associations of regional longitudinal (A and B) and radial (C and D) left ventricular strain and
strain rate with blood lead and 24-hour urinary cadmium. Both biomarkers were simultaneously entered into
the models. Associations were adjusted for sex, age, mean arterial pressure, heart rate, body mass index,
fasting plasma glucose, total-HDL cholesterol ratio, serum creatinine, c-glutamyltransferase, smoking, and
antihypertensive treatment (by drug class) and express the effect size for a doubling of the exposure
biomarker. Horizontal bars indicate the 95% conﬁdence interval. Measurements of longitudinal and radial
strain were available in 179 and 166 participants, respectively. HDL indicates high-density lipoprotein.
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the 1999-2006 NHANES data included 12 049 participants,
aged 30 years and older, of whom 471 reported a history of
heart failure.16 In multivariable-adjusted analyses a 50%
higher blood or urinary cadmium concentration was associ-
ated with a 48% (95% CI 17% to 87%) and 12% (95% CI 3% to
20%) higher odds of self-reported prevalent heart failure.16
Among 3348 Native Americans aged 45 to 74 years enrolled
in the Strong Heart Study, the urinary cadmium level at
baseline (1989-1991) averaged 0.94 lg (8.0 nmol) per gram
creatinine.17 Over follow-up until December 2008, 328
participants developed heart failure. The hazard ratio con-
trasting the 80th with the 20th percentile of urinary cadmium
was 1.39 (95% CI 1.01-1.94).17 The Malm€o Diet and Cancer
Study15 enrolled 4378 Swedes. Over 17 years of follow-up,
143 participants (47% women) were hospitalized for new-
onset heart failure. The multivariable-adjusted hazard ratio
contrasting the top vs the lowest fourth of the blood cadmium
distribution was 1.95 (95% CI 1.02-3.71). None of the
aforementioned studies in workers or populations differenti-
ated between systolic and diastolic dysfunction. All population
studies15,17,19,37,38 focused on heart failure, the end stage of
a long-lasting process with varying etiology.
Compared with the literature, our current study stands out
because of its prospective design, because it focused on the
earliest stages of left ventricular dysfunction rather than on
overt heart failure, an end-stage syndrome covering a wide
range of etiologies, because it applied state-of-the-art
echocardiographic techniques, and because it differentiated
between systolic and diastolic left ventricular function.
Moreover, animal studies showing evidence for direct car-
diotoxic effects in the absence of overt heavy-metal toxicity8,9
and the high prevalence of asymptomatic left ventricular
dysfunction in the general population28,29,39 justiﬁed our
approach. Decreased global left ventricular strain is a strong
predictor of cardiovascular mortality.29 Notwithstanding these
strong points, our study should be interpreted within the
context of its possible limitations. First, our observational
study does not allow inferring causality for lead or cadmium
as instigators of left ventricular dysfunction. However, several
of the Bradford-Hill criteria are fulﬁlled, including temporality,
a dose-effect association, and plausibility.40 Second, many of
our baseline data (39.1%) were collected from 1985 until
1989. In this period, blood lead averaged 0.42 lmol/L
(8.72 lg/dL), and 24-hour urinary cadmium 10.6 nmol
(1.19 lg). In participants with repeat assessment of their
exposure, blood lead dropped by 35.7% over ~5 years. Along
similar lines, in the United States NHANES documented a
progressive decline in the geometric blood lead concentration
over time. Among adults, mean blood lead levels decreased
from 0.63 lmol/L (13.1 lg/dL) in NHANES II (1976-
1980)41,42 to 0.13 lmol/L (2.76 lg/dL) in NHANES III
(1988-1994)43 and next to 0.07 lmol/L (1.51 lg/dL) in
NHANES IV (2003-2010).44 Thus, in the developed world
current exposure levels are substantially lower than noticed in
our study. Whether, at these lower exposure levels, the risk of
left ventricular dysfunction remains elevated is unknown.
Third, exposure to lead and cadmium often coexist. Our
current analyses did not allow us to differentiate among lead,
cadmium, and both combined as being predominantly asso-
ciated with regional systolic left ventricular function. However,
global longitudinal strain was associated only with the blood
lead concentration and not with 24-hour urinary cadmium.
The most consistent association was therefore with blood
lead. Fourth, our multivariable-adjusted models accounted for
a large number of variables with known physiological
relevance. However, as in all observational studies, we cannot
exclude residual confounding by factors, either unmeasured
or not entered into the models. Finally, our analyses included
only the 21.6% of people who underwent an echocardio-
graphic examination.
Conclusions
Although the effect sizes in our study were small, environ-
mental exposure to lead, cadmium, or both might be a risk
factor for systolic left ventricular dysfunction and in the end
for heart failure. Our current study is a ﬁrst attempt to
address the association of systolic and diastolic left ventric-
ular function with low-level exposure to heavy metals, as it is
still being observed in Western industrialized countries and
Table 5. Multivariable-Adjusted Association of Diastolic Left
Ventricular Function (2005-2010) With the Exposure
Biomarkers (1985-2004) in 179 Participants
Characteristic Biomarker
Estimate (95% Conﬁdence
Interval) P Value
E peak,
cm/s
Blood lead 1.308 (1.120 to 3.736) 0.289
Urinary
cadmium
1.309 (4.107 to 1.490) 0.357
E/A ratio Blood lead 0.036 (0.085 to 0.014) 0.159
Urinary
cadmium
0.010 (0.048 to 0.068) 0.734
e0 peak,
cm/s
Blood lead 0.188 (0.494 to 0.118) 0.228
Urinary
cadmium
0.017 (0.371 to 0.337) 0.925
E/e0 ratio Blood lead 0.172 (0.133 to 0.477) 0.267
Urinary
cadmium
0.065 (0.417 to 0.287) 0.716
E/A is the ratio of the peak early to the peak late diastolic velocity of the transmitral
blood ﬂow. Associations were adjusted for sex, age, mean arterial pressure, heart rate,
body mass index, fasting plasma glucose, total-to-HDL cholesterol ratio, serum
creatinine, c-glutamyltransferase, smoking, and antihypertensive treatment (by drug
class) and express the effect size for a doubling of the exposure biomarker. HDL
indicates high-density lipoprotein.
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most developing nations. Experimental research should clarify
the cardiotoxic mechanisms of lead and cadmium. Further-
more, our current ﬁndings need replication in prospective
population studies, in particular at exposure levels lower than
those seen in the present study. In the meantime, reducing
exposure and sanitization of contaminated soils, where
needed, are of primary importance. However, given the long
half-lives of lead and cadmium in the human body, preventing
exposure might not be sufﬁcient once exposure has occurred.
Health care providers should be made aware of the risks
associated with environmental exposure to cardiotoxic
agents. Although nowadays stringent regulations protect
workers, the same does not always hold true for populations
living in historically polluted regions, such as, for instance,
part of the catchment area of our current study.
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